FLAM
PVLA

First Light Asset Management’s Palvella Therapeutics PVLA Stock Holding History

First Light Asset Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118M Sell
771,901
-208,857
-21% -$25.4M 7.17% 5
2026
Q1 		$122M Buy
980,758
+271,617
+38% +$28.3M 10.96% 2
2025
Q4 		$74.2M Buy
709,141
+167,597
+31% +$14.3M 5.67% 4
2025
Q3 		$33.9M Buy
+541,544
New +$24.1M 3.2% 8

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

First Light Asset Management's PVLA Position: Q2 2026 in Review

First Light Asset Management reduced its Palvella Therapeutics (PVLA) stake by 21% in Q2 2026, selling an estimated $25.4M and leaving 771,901 shares worth $118M. The position accounts for 7.17% of the portfolio, ranked #5.

First Light Asset Management first reported a position in PVLA in Q3 2025 and has held it in 4 quarters since. The position peaked at $122M in Q1 2026. 197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • First Light Asset Management held 771,901 shares of Palvella Therapeutics worth $118M as of Q2 2026.
  • First Light Asset Management sold 208,857 Palvella Therapeutics shares in Q2 2026, an estimated $25.4M.
  • Palvella Therapeutics made up 7.17% of First Light Asset Management's portfolio in Q2 2026, its #5 holding.
  • First Light Asset Management first reported a position in Palvella Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • First Light Asset Management's Palvella Therapeutics position peaked at $122M in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.